This webinar provides a detailed discussion of the differences between current drug development for oncology products and that employed in other therapeutic areas. Oncology drugs, like other agents, pass through a development sequence of three major phases. However, clinical development of oncology drugs has many important differences from that of other therapeutic agents. This presentation will highlight and explain the reasons for these differences.
Robert Earhart, MD, PhD
Arrowsmith Oncology LLC
PERI Course Code: WA2
Full Archive Available for Purchase: $275 for 30-days unlimited access
Call PERI at 703-276-0178 for details.